Influenza Myocarditis Treated With Antithymocyte Globulin

Area of Science:

• Pediatric Cardiology
• Infectious Diseases
• Immunology

Background:

• Influenza causes significant global morbidity and mortality.
• Myocarditis is a rare but severe complication of influenza, particularly in children.
• Current treatments for viral myocarditis are primarily supportive, with immunomodulatory therapies sometimes used.

Observation:

• A pediatric patient presented with acute fulminant influenza B myocarditis.
• The condition was severe, necessitating mechanical circulatory support.
• T cells are implicated in myocyte damage through antibody production in myocarditis.

Findings:

• Antithymocyte globulin targets T cells, which are hypothesized to cause myocyte damage.
• The patient showed improvement following treatment with antithymocyte globulin.
• This suggests a potential therapeutic role for antithymocyte globulin in severe influenza B myocarditis.

Implications:

• Antithymocyte globulin may offer a novel treatment option for severe influenza B myocarditis in children.
• Further research is warranted to explore the efficacy and safety of antithymocyte globulin in this context.
• Understanding the role of T cells in influenza-induced myocarditis can guide future therapeutic strategies.